Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept.
Boender AJ, Boon M, Albers HE, Eck SR, Fricker BA, Kelly AM, LeDoux JE, Motta SC, Shrestha P, Taylor JH, Trainor BC, Triana-Del Rio R, Young LJ
Sci Adv. 2023 Jun 2;9(22):eadf4950. doi: 10.1126/sciadv.adf4950. Epub 2023 May 31.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
194015pAAV-U6-sgRNA(OXTR.1)-CMV-eGFPExpresses a gRNA that targets OXTR coding sequence in multiple (rodent) species and eGFP
194016pAAV-U6-sgRNA(OXTR.2)-CMV-eGFPExpresses a gRNA that targets OXTR coding sequence in multiple (rodent) species and eGFP
194017pAAV-U6-sgRNA(CTRL)-CMV-eGFPExpresses a gRNA that targets the LacZ gene (serves as control) and eGFP

Antibodies from Article